The duration of measuring partial AUCs for the assessment of bioequivalence

Pharmaceutical Research

Volumn 15, Issue 3, 1998, Pages 399-404

  Endrenyi, Laszlo ^a   Csizmadia, Ferenc ^a   Tothfalusi, Laszlo ^a   Balch, Alfred H ^b   Chen, Mei Ling ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Absorption rate; Bioequivalence; Crossover trials; Experimental design; Partial AUC

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; AVERAGE; BIOEQUIVALENCE; COMPUTER SIMULATION; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; KINETICS; PRIORITY JOURNAL; SAMPLING; TECHNIQUE;

AREA UNDER CURVE; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, THEORETICAL; PHARMACOKINETICS; THERAPEUTIC EQUIVALENCY;

EID: 0031944438     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011916113082     Document Type: Article

References (12)

1. M-L. Chen. An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 9:1380-1385 (1992).
2. T. N. Tozer, F. Y. Bois, W. W. Hauck, M-L. Chen, and R. L. Williams. Absorption rate vs. exposure: which is more useful for bioequivalence testing? Pharm. Res. 13:453-456 (1996).
3. K. K. Midha, J. W. Hubbard, M. Rawson, and L. Gavalas. The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: experimental evidence. Eur. J. Pharm. Sci. 2:351-363 (1994).
4. L. Endrenyi and L. Tothfalusi. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives. Int. J. Clin. Pharmacol. Ther. 35:142-150 (1997).
5. F. Y. Bois, T. N. Tozer, W. W. Hauck, M. L. Chen, R. Patnaik, and R. L. Williams. Bioequivalence: performance of several measures of rate of absorption. Pharm. Res. 11:966-974 (1994).
6. F. Y. Bois, T. N. Tozer, W. W. Hauck, M. L. Chen, R. Patnaik, and R. L. Williams. Bioequivalence: performance of several measures of extent of absorption. Pharm. Res. 11:715-722 (1994).
7. max/AUC is an effective metric in investigations of bioequivalence. Pharm. Res. 12:937-942 (1995).
8. J. Zha, L. Tothfalusi, and L. Endrenyi. Properties of metrics applied for the evaluation of bioequivalence. Drug Inf. J. 29:989-996 (1994).
9. max for absorption rates in investigations of bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:394-399 (1991).
10. P. Macheras, M. Symillides, and C. Reppas. The cutoff time point of the partial area method for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 11:831-834 (1994).
11. L. Endrenyi and P. Al-Shaikh. Sensitive and specific determination of the equivalence of absorption rates. Pharm. Res. 12:1856-1864 (1995).
12. P. Macheras, M. Symillides, and C. Reppas. An improved intercept method for the assessment of absorption rate in bioequivalence studies. Pharm. Res. 13:1755-1758 (1996).